Published in J Hepatol on January 07, 2010
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10
Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. Korean J Hepatol (2011) 0.87
Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci (2014) 0.85
A new look at renal dysfunction in the cirrhotic patient. Crit Care (2012) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis. World J Gastroenterol (2011) 0.82
Long-term remote organ consequences following acute kidney injury. Crit Care (2015) 0.82
Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction. Clin Transplant (2014) 0.81
Renal dysfunction in patients with cirrhosis: Where do we stand? World J Gastrointest Pharmacol Ther (2014) 0.80
GFR Estimating Equations and Liver Disease. Adv Chronic Kidney Dis (2015) 0.79
Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease. Gastroenterol Res Pract (2015) 0.78
Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol (2014) 0.78
Evaluation of renal function in patients with cirrhosis: where are we now? World J Gastroenterol (2014) 0.78
Renal impairment in cirrhosis unrelated to hepatorenal syndrome. Can J Gastroenterol Hepatol (2015) 0.77
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis. BMC Nephrol (2015) 0.77
Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol (2012) 0.77
Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury. Int J Nephrol (2014) 0.77
Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure. PLoS One (2015) 0.77
The 24 hour urine creatinine clearance for prediction of glomerular filtration rate in liver cirrhosis patients: have we considered all elements? Hepat Mon (2013) 0.76
Evaluation of renal function in patients with cirrhosis. J Hepatol (2010) 0.76
Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. Adv Chronic Kidney Dis (2015) 0.76
The factors affecting bone density in cirrhosis. Hepat Mon (2015) 0.76
Osseous and Nonosseous Bone Scan Findings in Liver Transplant Candidates with end-stage Chronic Liver Disease. Mol Imaging Radionucl Ther (2013) 0.75
Management options in decompensated cirrhosis. Hepat Med (2015) 0.75
Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol (2016) 0.75
Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterol Res Pract (2015) 0.75
The Relationship between Renal Dysfunction and Abnormalities of the Immune System in Patients with Decompensated Cirrhosis. ISRN Gastroenterol (2012) 0.75
Acute kidney injury in liver cirrhosis: new definition and application. Clin Mol Hepatol (2016) 0.75
The evolving concept of acute kidney injury in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2015) 0.75
Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis. Scand J Gastroenterol (2013) 0.75
Renal dysfunction in cirrhosis. Curr Opin Gastroenterol (2015) 0.75
Doppler parameters of hepatic and renal hemodynamics in patients with liver cirrhosis. Int J Nephrol (2012) 0.75
Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep (Oxf) (2017) 0.75
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med (2011) 8.50
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology (2010) 8.11
Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31
Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet (2012) 4.85
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology (2007) 3.75
Acute-on chronic liver failure. J Hepatol (2012) 3.74
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46
Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol (2006) 3.14
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology (2003) 3.00
Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol (2010) 2.66
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. J Hepatol (2011) 2.59
Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology (2003) 2.57
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology (2003) 2.43
Severe sepsis in cirrhosis. Hepatology (2009) 2.33
Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int (2010) 2.32
Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology (2014) 2.22
Autophagy in liver diseases. J Hepatol (2010) 2.06
Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int (2008) 2.06
Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg (2003) 2.03
Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med (2010) 1.94
Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl (2010) 1.81
Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology (2014) 1.81
Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant (2005) 1.79
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int (2009) 1.76
Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology (2012) 1.69
Management of critically-ill cirrhotic patients. J Hepatol (2012) 1.65
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology (2012) 1.64
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Kidney Int (2011) 1.64
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One (2010) 1.54
High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology (2007) 1.50
Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol (2013) 1.50
Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies? Nephrol Dial Transplant (2006) 1.44
Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology (2003) 1.42
Noninvasive assessment of portal hypertension in patients with cirrhosis. Hepatology (2011) 1.42
In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. J Pathol (2010) 1.41
Liver transplantation for hepatocellular carcinoma: should we push the limits? Liver Transpl (2003) 1.39
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis. Am J Gastroenterol (2002) 1.39
Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia. Nephrol Dial Transplant (2005) 1.39
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother (2012) 1.39
Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med (2002) 1.34
Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology (2008) 1.34
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology (2006) 1.34
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology (2007) 1.33
Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol (2008) 1.29
Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology (2003) 1.28
Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl (2004) 1.26
NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol (2010) 1.25
Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl (2010) 1.24
Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol (2004) 1.23
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol (2002) 1.20
NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans (2008) 1.20
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology (2010) 1.14
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation (2003) 1.13
Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One (2012) 1.11
Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol (2010) 1.11
Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology (2007) 1.11
Central role of mitochondria in drug-induced liver injury. Drug Metab Rev (2011) 1.10
Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A (2011) 1.10
Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol (2012) 1.09
Multifactorial aetiology of hepatic infarction: a case report with literature review. Eur J Gastroenterol Hepatol (2004) 1.09
Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis. Gastroenterology (2011) 1.09
In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother (2011) 1.09
Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol (2011) 1.07
Portomesenteric shunt for liver transplantation and complete portal vein thrombosis. Transplantation (2013) 1.07
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J Hepatol (2012) 1.06
Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother (2014) 1.06
Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology (2014) 1.05
Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients. J Clin Microbiol (2003) 1.04
Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int (2003) 1.02
Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med (2013) 1.01
Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother (2010) 0.99
Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology (2009) 0.99
Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int (2002) 0.99
Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France. Kidney Int (2005) 0.99
Lipopolysaccharide-induced mitochondrial DNA depletion. Antioxid Redox Signal (2011) 0.95
Toxoplasma gondii triggers secretion of interleukin-12 but low level of interleukin-10 from the THP-1 human monocytic cell line. Cytokine (2007) 0.95
Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. J Hepatol (2006) 0.94
Immunological function of the endothelial cell within the setting of organ transplantation. Immunol Lett (2011) 0.94
Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol (2010) 0.94
Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation (2003) 0.93
Renal biopsy practice in France: results of a nationwide study. Nephrol Dial Transplant (2010) 0.93
Hepatic mitochondrial DNA depletion after an alcohol binge in mice: probable role of peroxynitrite and modulation by manganese superoxide dismutase. J Pharmacol Exp Ther (2009) 0.93
Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro. Acta Neuropathol (2004) 0.93